Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lumacaftor 100mg / Ivacaftor 125mg granules sachets
0307000T0AAACAC
|
Lumacaftor/ivacaftor | Lumacaftor/ivacaftor | Respiratory System | No data available |
|
Lumacaftor 100mg / Ivacaftor 125mg tablets
0307000T0AAABAB
|
Lumacaftor/ivacaftor | Lumacaftor/ivacaftor | Respiratory System | No data available |
|
Lumacaftor 150mg / Ivacaftor 188mg granules sachets
0307000T0AAADAD
|
Lumacaftor/ivacaftor | Lumacaftor/ivacaftor | Respiratory System | No data available |
|
Lumacaftor 200mg / Ivacaftor 125mg tablets
0307000T0AAAAAA
|
Lumacaftor/ivacaftor | Lumacaftor/ivacaftor | Respiratory System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.